Newsletter

This month in Pep Talk read our blog on Designing biomimetic neural materials for scalable 3D cell culture, read our Technote on VEGF 165 and learn more about NT-3 from our neural stem cell range.

This month in Pep Talk we discuss species-specific growth factors, our cellular agriculture promotion, events this month and our image and video competition

This month: Shh now available, new lab start up promotion, our paper recommendation of the month and free poster download

This month: Bovine/porcine FGF-2 out now, Qkine scale up manufacturing, why you should check vial recovery as part of your QC, and our latest blog article on our internship.

This month: download our latest poster on human pluripotent stem cell-directed differentiation, read a recent review article on human organoids and visit us in person at one of our upcoming events

This month: free growth factors for summer projects, GDNF, mLIF vs ESGRO and our new blog, the difference between growth factors and cytokines

This month: on-demand webinar, can R-spondin1 recombinant protein replace conditioned media? and enter our photo competition

this month: TGFbeta3 launched, photo competition now open and are endoderm implants the future of medicine?

In this months pep talk we explore why quality isn't just about purity and a product spotlight on BMP-4 lot comparibility.

On Friday, 11th February, it’s International Day of Women and Girls in Science 2022. To celebrate, I’d like to give a big shout-out to people of all genders who champion gender equality in science and inspire the next generations of scientists, thank you!

Happy New Year! It’s five years since Marko and I founded Qkine, the time has flown. Highlights have been the wonderful feedback we’ve had from customers and launching innovative products such as the first true animal-free TGFβ1, tag-free thermostable FGF2-G3, and demonstrating the efficacy of HGF NK1 in hepatocyte differentiation.

There has been an impressive drive towards innovation in stem cell protocols this year. As 2021 comes to a close, we reflect on the highlights for stem cell science over the year. It was great to see new culture media, such as B8 and “Beefy-9”, published, developments in cultivated meat science hit the news and iPSC-based therapies edge closer to the clinic. Reproducibility remains the underlying theme, and indeed requirement, for maximising the impact of these wonderful developments and at Qkine we’ll continue to do everything we can to help in 2022.